These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35271762)

  • 1. Association between sarcopenia and the severity of diabetic polyneuropathy assessed by nerve conduction studies in Japanese patients with type 2 diabetes mellitus.
    Mikura K; Kodama E; Iida T; Imai H; Hashizume M; Kigawa Y; Tadokoro R; Sugisawa C; Endo K; Iizaka T; Otsuka F; Nagasaka S
    J Diabetes Investig; 2022 Aug; 13(8):1357-1365. PubMed ID: 35271762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point-of-care nerve conduction device predicts the severity of diabetic polyneuropathy: A quantitative, but easy-to-use, prediction model.
    Kamiya H; Shibata Y; Himeno T; Tani H; Nakayama T; Murotani K; Hirai N; Kawai M; Asada-Yamada Y; Asano-Hayami E; Nakai-Shimoda H; Yamada Y; Ishikawa T; Morishita Y; Kondo M; Tsunekawa S; Kato Y; Baba M; Nakamura J
    J Diabetes Investig; 2021 Apr; 12(4):583-591. PubMed ID: 32799422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroretinal dysfunction revealed by a flicker electroretinogram correlated with peripheral nerve dysfunction and parameters of atherosclerosis in patients with diabetes.
    Kawai M; Himeno T; Shibata Y; Hirai N; Asada-Yamada Y; Asano-Hayami E; Ejima Y; Kasagi R; Nagao E; Sugiura-Roth Y; Nakai-Shimoda H; Nakayama T; Yamada Y; Ishikawa T; Morishita Y; Kondo M; Tsunekawa S; Kato Y; Nakamura J; Kamiya H
    J Diabetes Investig; 2021 Jul; 12(7):1236-1243. PubMed ID: 33210835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simplified electrophysiological approach combining a point-of-care nerve conduction device and an electrocardiogram produces an accurate diagnosis of diabetic polyneuropathy.
    Hayashi Y; Himeno T; Shibata Y; Hirai N; Asada-Yamada Y; Sasajima S; Asano-Hayami E; Motegi M; Asano S; Kato M; Nakai-Shimoda H; Tani H; Miura-Yura E; Morishita Y; Kondo M; Tsunekawa S; Nakayama T; Nakamura J; Kamiya H
    J Diabetes Investig; 2024 Jun; 15(6):736-742. PubMed ID: 38421109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Progression of Polyneuropathy Over 5 Years in Patients With Type 2 Diabetes.
    Brask-Thomsen PK; Itani M; Karlsson P; Kristensen AG; Krøigård T; Jensen TS; Tankisi H; Sindrup SH; Finnerup NB; Gylfadottir SS
    Neurology; 2024 Aug; 103(3):e209652. PubMed ID: 39008800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with diabetic polyneuropathy-related sensory symptoms and signs in patients with polyneuropathy: A cross-sectional Japanese study (JDDM 52) using a non-linear model.
    Yokoyama H; Tsuji T; Hayashi S; Kabata D; Shintani A
    J Diabetes Investig; 2020 Mar; 11(2):450-457. PubMed ID: 31314173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of left ventricular myocardial dysfunction with diabetic polyneuropathy.
    Tabako S; Harada M; Sugiyama K; Ohara H; Ikeda T
    J Med Ultrason (2001); 2019 Jan; 46(1):69-79. PubMed ID: 30155803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the severity of diabetic polyneuropathy aids in predicting the risk of developing diabetic complications in patients with untreated diabetes.
    Horinouchi S; Deguchi T; Mukai M; Ijuin A; Kawamoto Y; Nishio Y
    Front Endocrinol (Lausanne); 2024; 15():1380970. PubMed ID: 38559690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between diabetic peripheral neuropathy and sarcopenia: A systematic review and meta-analysis.
    Wannarong T; Sukpornchairak P; Naweera W; Geiger CD; Ungprasert P
    Geriatr Gerontol Int; 2022 Sep; 22(9):785-789. PubMed ID: 36053982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of neuropathy subtypes in type 1 diabetes.
    Karlsson P; Sjogaard MB; Schousboe K; Mizrak HI; Kufaishi H; Staehelin Jensen T; Randel Nyengaard J; Hansen CS; Yderstræde KB; Buhl CS
    BMJ Open Diabetes Res Care; 2024 Jul; 12(4):. PubMed ID: 39025795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between deterioration in muscle strength and peripheral neuropathy in people with diabetes.
    Oh TJ; Kang S; Lee JE; Moon JH; Choi SH; Lim S; Jang HC
    J Diabetes Complications; 2019 Aug; 33(8):598-601. PubMed ID: 31129004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between asymptomatic median mononeuropathy and diabetic polyneuropathy severity in patients with diabetes mellitus.
    Stamboulis E; Voumvourakis K; Andrikopoulou A; Koutsis G; Tentolouris N; Kodounis A; Tsivgoulis G
    J Neurol Sci; 2009 Mar; 278(1-2):41-3. PubMed ID: 19059612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low muscle quality in Japanese type 2 diabetic patients with visceral fat accumulation.
    Murai J; Nishizawa H; Otsuka A; Fukuda S; Tanaka Y; Nagao H; Sakai Y; Suzuki M; Yokota S; Tada H; Doi M; Fujishima Y; Kita S; Funahashi T; Maeda N; Nakamura T; Shimomura I
    Cardiovasc Diabetol; 2018 Aug; 17(1):112. PubMed ID: 30077183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of peripheral neuropathy with skeletal muscle mass and function in type two diabetes mellitus patients: A cross-sectional study.
    Mohapatra S; Ramachandran M; Behera KK; Priyadarsini N; Nanda P; Devi S
    Endocrinol Diabetes Nutr (Engl Ed); 2022 Oct; 69(8):591-599. PubMed ID: 36446485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of sarcopenia and muscle mass with both peripheral neuropathy and nerve function in patients with type 2 diabetes.
    Zhang Y; Shen X; He L; Zhao F; Yan S
    Diabetes Res Clin Pract; 2020 Apr; 162():108096. PubMed ID: 32109517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between macro- and microvascular damage and sarcopenia index in individuals with type 2 diabetes mellitus.
    Xu H; Xiang QY; Zhan JK; Wang Y; Wang YJ; Li S; Liu YS
    Appl Physiol Nutr Metab; 2024 Jun; 49(6):762-772. PubMed ID: 38346295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and prevalence of diabetic polyneuropathy: a cross-sectional study of Danish patients with type 2 diabetes.
    Gylfadottir SS; Itani M; Krøigård T; Kristensen AG; Christensen DH; Nicolaisen SK; Karlsson P; Callaghan BC; Bennett DL; Andersen H; Tankisi H; Nielsen JS; Andersen NT; Jensen TS; Thomsen RW; Sindrup SH; Finnerup NB
    Eur J Neurol; 2020 Dec; 27(12):2575-2585. PubMed ID: 32909392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence and clinical impact of dynapenia and sarcopenia in Japanese patients with type 1 and type 2 diabetes: Findings from the Impact of Diabetes Mellitus on Dynapenia study.
    Mori H; Kuroda A; Yoshida S; Yasuda T; Umayahara Y; Shimizu S; Ryomoto K; Yoshiuchi K; Yamamoto T; Matsuoka TA; Shimomura I; Matsuhisa M
    J Diabetes Investig; 2021 Jun; 12(6):1050-1059. PubMed ID: 33063949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative vibration perception threshold in assessing diabetic polyneuropathy: Should the cut-off value be adjusted for Chinese individuals with type 2 diabetes?
    Liu M; Gao Y; Chen DW; Lin S; Wang C; Chen LH; Ran XW
    J Diabetes Investig; 2021 Sep; 12(9):1663-1670. PubMed ID: 33512757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corneal confocal microscopy as a tool for detecting diabetic polyneuropathy in a cohort with screen-detected type 2 diabetes: ADDITION-Denmark.
    Andersen ST; Grosen K; Tankisi H; Charles M; Andersen NT; Andersen H; Petropoulos IN; Malik RA; Jensen TS; Karlsson P
    J Diabetes Complications; 2018 Dec; 32(12):1153-1159. PubMed ID: 30309785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.